ERAP1 shapes just part of the immunopeptidome

被引:27
作者
Admon, Arie [1 ]
机构
[1] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel
基金
以色列科学基金会;
关键词
ERAP1; MHC; HLA; Peptidome; Immunopeptidome; MHC CLASS-I; ENDOPLASMIC-RETICULUM AMINOPEPTIDASES; ANTIGEN PRESENTATION; ER AMINOPEPTIDASE; BEHCETS-DISEASE; TRANSGENIC RATS; AUTOPHAGY PROTEINS; CROSS-PRESENTATION; TRIMS PRECURSORS; STRUCTURAL BASIS;
D O I
10.1016/j.humimm.2019.03.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ERAP1 is an aminopeptidase involved in trimming long peptides to the lengths required for presentation by MHC class I. ERAP1 substrate preference is for peptides with hydrophobic or aliphatic N-terminal amino acids, with lower efficacy with charged and small hydrophilic amino acids and almost complete inefficiency with proline. Since ERAP1 efficiently trims peptides to eight amino acids or even shorter, and many MHC-I allotypes can only bind peptides that are eight or nine amino acids or longer, ERAP1 both produces and destroys potential ligands of these alleles. The observation that ERAP1 modulates the levels of presentation for only a subset of the immunopeptidome conflicts with the common assumption that most MHC-I peptides are derived from longer peptides that are produced by the proteasome, transported into the endoplasmic reticulum (ER) by the Transporter Associated Peptide Presentation (TAP) and then trimmed by ERAP1. A more likely mechanism is that cellular protein degradation produces surplus amounts of peptides that fit perfectly and are rapidly loaded onto the MHC, with only a minority of peptides requiring trimming within the ER before loading. Alternatively, ERAP1 may not be present in all ER compartments or vesicles where peptide processing and loading take place and thus affects just a subset of the immunopeptidome.
引用
收藏
页码:296 / 301
页数:6
相关论文
共 97 条
[1]   Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction [J].
Abelin, Jennifer G. ;
Keskin, Derin B. ;
Sarkizova, Siranush ;
Hartigan, Christina R. ;
Zhang, Wandi ;
Sidney, John ;
Stevens, Jonathan ;
Lane, William ;
Zhang, Guang Lan ;
Eisenhaure, Thomas M. ;
Clauser, Karl R. ;
Hacohen, Nir ;
Rooney, Michael S. ;
Carr, Steven A. ;
Wu, Catherine J. .
IMMUNITY, 2017, 46 (02) :315-326
[2]   Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides [J].
Admon, A ;
Barnea, E ;
Ziv, T .
MOLECULAR & CELLULAR PROTEOMICS, 2003, 2 (06) :388-398
[3]   The Human Immunopeptidome Project, a Suggestion for yet another Postgenome Next Big Thing [J].
Admon, Arie ;
Bassani-Sternberg, Michal .
MOLECULAR & CELLULAR PROTEOMICS, 2011, 10 (10)
[4]  
Allen RL, 1999, J IMMUNOL, V162, P5045
[5]   Gapped sequence alignment using artificial neural networks: application to the MHC class I system [J].
Andreatta, Massimo ;
Nielsen, Morten .
BIOINFORMATICS, 2016, 32 (04) :511-517
[6]   Formation of HLA-B27 homodimers and their relationship to assembly kinetics [J].
Antoniou, AN ;
Ford, S ;
Taurog, JD ;
Butcher, GW ;
Powis, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) :8895-8902
[7]  
Barnea E, 2002, EUR J IMMUNOL, V32, P213, DOI 10.1002/1521-4141(200201)32:1<213::AID-IMMU213>3.3.CO
[8]  
2-#
[9]   The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion [J].
Barnea, Eilon ;
Kadosh, Dganit Melamed ;
Haimovich, Yael ;
Satumtira, Nimman ;
Dorris, Martha L. ;
Nguyen, Mylinh T. ;
Hammer, Robert E. ;
Tran, Tri M. ;
Colbert, Robert A. ;
Taurog, Joel D. ;
Admon, Arie .
MOLECULAR & CELLULAR PROTEOMICS, 2017, 16 (04) :642-662
[10]   Mass spectrometry-based antigen discovery for cancer immunotherapy [J].
Bassani-Sternberg, Michal ;
Coukos, George .
CURRENT OPINION IN IMMUNOLOGY, 2016, 41 :9-17